AI assistant
Sending…
NATIONAL RESEARCH CORP — Director's Dealing 2020
Nov 27, 2020
33341_dirs_2020-11-27_7bdc38d1-bbf2-4947-becd-368cbee8f5ec.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NATIONAL RESEARCH CORP (NRC)
CIK: 0000070487
Period of Report: 2020-11-17
Reporting Person: RAASCH JONA S (COO, NRC Health)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50619 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $13.17 | 2025-01-06 | Common Stock (23581) | Direct | |
| Employee Stock Option (right to buy) | $15.23 | 2026-01-05 | Common Stock (21535) | Direct | |
| Employee Stock Option (right to buy) | $18.80 | 2027-01-04 | Common Stock (17608) | Direct | |
| Employee Stock Option (right to buy) | $36.80 | 2028-01-03 | Common Stock (12228) | Direct | |
| Employee Stock Option (right to buy) | $38.30 | 2029-01-03 | Common Stock (11749) | Direct | |
| Employee Stock Option (right to buy) | $65.80 | 2030-01-03 | Common Stock (6839) | Direct |
More from NATIONAL RESEARCH CORP
Regulatory Filings
2026
May 13
Annual Report
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Proxy Solicitation & Information Statement
2026
May 8
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
Apr 28
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20